EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis

Changqin Chen, Wenchao Mao, Changyun Zhao, Difan Lu, Weihang Hu, Jianqiang Xiong

European Journal of Clinical Microbiology & Infectious Diseases · 2026-07 · 45 (7) · 1941-1951

DOI: 10.1007/s10096-026-05482-9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 20.03.2026. Verfasst von Changqin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AztreonamAztreonam-AvibactamBest Available TherapyCeftazidime-AvibactamMeta-Analysis

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China.
  • Cardiovascular Ultrasound Center of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310000, China.
  • Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China. zjyyxjq@163.com.

Förderung

  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Chen, C., Mao, W., Zhao, C., Lu, D., Hu, W., & Xiong, J. (2026). Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis. European Journal of Clinical Microbiology & Infectious Diseases, 45(7), 1941-1951. https://doi.org/10.1007/s10096-026-05482-9

Vancouver

Chen C, Mao W, Zhao C, Lu D, Hu W, Xiong J. Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis. European Journal of Clinical Microbiology & Infectious Diseases. 2026;45(7):1941-1951. doi:10.1007/s10096-026-05482-9

BibTeX
@article{Chen2026,
  author = {Chen, Changqin and Mao, Wenchao and Zhao, Changyun and Lu, Difan and Hu, Weihang and Xiong, Jianqiang},
  title = {Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {1941--1951},
  doi = {10.1007/s10096-026-05482-9}
}
Kostenlos starten →